This compound is a pharmaceutical intermediate featuring a pyrrolidine ring with bromoacetyl and benzyl ester substituents. It is primarily used in the manufacturing of active pharmaceutical ingredients.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 1428243-26-8
(3R,4S)-1-((benzyloxy)carbonyl)-4-ethylpyrrolidine-3-carboxylic acid Dicyclohexylamine Salt
pharmaceutical intermediate
(3R,4S)-1-((Benzyloxy)carbonyl)-4-ethylpyrrolidine-3-carboxylic acid
pharmaceutical intermediate
8-((3R,4S)-4-ethylpyrrolidin-3-yl)-3-tosyl-3H-imidazo[1,2-a]pyrrolo[2,3-e]pyrazine
pharmaceutical intermediate
4-Desmethoxy-4-nitro omeprazole sulfide
pharmaceutical intermediate
N1-methylpseudouridine-5'-triphosphate
pharmaceutical intermediate
Fezolinetant Impurity 3
pharmaceutical intermediate
Benzyl (3S,4S)-3-(2-bromoacetyl)-4-ethylpyrrolidine-1-carboxylate
pharmaceutical intermediate
Sulfoxonium, (2-((3R,4S)-4-ethyl-1-((phenylmethoxy)carbonyl)-3-pyrrolidinyl)-2-oxoethyl)dimethyl-, inner salt, rel-
pharmaceutical intermediate
benzyl (3R,4S)-3-(2-bromoacetyl)-4-ethylpyrrolidine-1-carboxylate
QEFUCTKHMXMWRF-KGLIPLIRSA-N
CC[C@@H]1CN(C[C@@H]1C(=O)CBr)C(=O)OCC2=CC=CC=C2